$204.45+36.78% · 3M
Moving avg
1W-0.34%
1M+10.85%
3M+40.36%
6M+112.28%
YTD+158.73%
1Y+467.60%
3Y+581.50%
5Y+698.32%
52-week range
$34.00100% of range$193.83
Company health
Value0/6
Growth0/6
Profitability0/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- Net cash on the balance sheet
Risks
- Burning free cash flow
- Revenue shrinking 11% a year
Key statistics
Valuation
Market cap
$43.47B
Enterprise value
$40.23B
P/E ratio (TTM)
-26.61x
P/S ratio (TTM)
0.00x
EV/EBITDA
-30.50x
Per share & returns
EPS (TTM)
-$6.92
Dividend yield
0.00%
Beta (1Y)
1.38
30-day change
+10.85%
Trading
Volume (24h)
227.51K
Previous close
$205.26
Shares outstanding
212.60M
About Revolution Medicines, Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
RVMD
Revolution Medicines, Inc. is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (United States) and trade under the ticker RVMD.
Frequently asked questions
What is Revolution Medicines, Inc.'s market cap?
Revolution Medicines, Inc. (RVMD) has a market capitalization of $43.47B.
What sector is Revolution Medicines, Inc. in?
Revolution Medicines, Inc. operates in the Healthcare sector, Biotechnology industry.
What exchange does RVMD trade on?
RVMD trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,218.39-0.15%
$1.15T cap
Johnson & JohnsonJNJ
$261.39+0.20%
$629.92B cap
AbbVie Inc.ABBV
$250.32+0.63%
$442.26B cap
UnitedHealth Group IncorporatedUNH
$402.17-0.84%
$365.22B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.77+1.39%
$332.86B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.76B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap